Annual Report 2024

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2024 89 The United Laboratories International Holdings Limited Annual Report 2024 7. OTHER GAINS AND LOSSES, NET 2024 2023 RMB’000 RMB’000 Net (gain) loss on fair value changes of derivative financial instruments (Note) (92,032) 12,399 Gain on disposal of financial assets at FVTPL (66,501) (72,748) Reversal of write-down of deposits for property, plant and equipment – (5,563) Net loss on disposal of property, plant and equipment 4,269 3,703 Written off of property, plant and equipment 23,297 47,955 Net foreign exchange gain (25,792) (9,452) Others 2,978 35 (153,781) (23,671) Note: During the years ended 31 December 2024 and 2023, the Group had entered into several foreign currency forward contracts with banks and financial institutions to reduce its exposure to foreign currency risks. These derivatives were not accounted for under hedge accounting. The Group did not hold any (2023: held three) derivative financial instruments as at 31 December 2024.